1983
DOI: 10.1016/0166-0934(83)90095-2
|View full text |Cite
|
Sign up to set email alerts
|

Optimal conditions for titration of SV40 by the plaque assay method

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0

Year Published

1985
1985
2009
2009

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 18 publications
1
5
0
Order By: Relevance
“…No inhibition of virus plaque-forming ability by agar was observed. This is consistent with several other viral assays that employ agar as an overlay (16)(17)(18).…”
Section: Source Of Viruses Cells and Virus Assays Vesicular Stomatisupporting
confidence: 91%
“…No inhibition of virus plaque-forming ability by agar was observed. This is consistent with several other viral assays that employ agar as an overlay (16)(17)(18).…”
Section: Source Of Viruses Cells and Virus Assays Vesicular Stomatisupporting
confidence: 91%
“…Based on these data, and based on the importance of TAg-Hsp70 interaction and Hsp70 activity during SV40 replication (see Section 1), we tested if MAL2-11B could inhibit viral replication using a well-established plaque assay (Fendrick and Hallick, 1983). BSC40 cells, an African green monkey kidney cell line permissive for SV40 replication, were plated and infected at a multiplicity of infection (MOI) of 2, and the infection was allowed to proceed for 2–3 h before the compounds were added at a final concentration of 100 µM.…”
Section: Resultsmentioning
confidence: 99%
“…Virus pools used in this study contained an average of 2.5 x lO s PFU/ml. The PFU were determined by plaque assay (11).…”
Section: Cells and Virusesmentioning
confidence: 99%